Related Experiment Video
Updated: Jun 3, 2026
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
An integrative approach to identifying cancer chemoresistance-associated pathways
Shih-Yi Chao1, Jung-Hsien Chiang, A-Mei Huang
1Department of Computer Science and Information Engineering, Ching Yun University, Jhongli City, Taoyuan County, Taiwan.
Background:
Resistance to chemotherapy severely limits the effectiveness of chemotherapy drugs in treating cancer. Still, the mechanisms and critical pathways that contribute to chemotherapy resistance are relatively unknown. This study elucidates the chemoresistance-associated pathways retrieved from the integrated biological interaction networks and identifies signature genes relevant for chemotherapy resistance.
Methods:
An integrated network was constructed by collecting multiple metabolic interactions from public databases and the k-shortest path algorithm was implemented to identify chemoresistant related pathways. The identified pathways were then scored using differential expression values from microarray data in chemosensitive and chemoresistant ovarian and lung cancers. Finally, another pathway database, Reactome, was used to evaluate the significance of genes within each filtered pathway based on topological characteristics.
Results:
By this method, we discovered pathways specific to chemoresistance. Many of these pathways were consistent with or supported by known involvement in chemotherapy. Experimental results also indicated that integration of pathway structure information with gene differential expression analysis can identify dissimilar modes of gene reactions between chemosensitivity and chemoresistance. Several identified pathways can increase the development of chemotherapeutic resistance and the predicted signature genes are involved in drug resistant during chemotherapy. In particular, we observed that some genes were key factors for joining two or more metabolic pathways and passing down signals, which may be potential key targets for treatment.
Conclusions:
This study is expected to identify targets for chemoresistant issues and highlights the interconnectivity of chemoresistant mechanisms. The experimental results not only offer insights into the mode of biological action of drug resistance but also provide information on potential key targets (new biological hypothesis) for further drug-development efforts.
Insights
This study identifies key biological pathways and signature genes linked to chemotherapy resistance, offering potential new targets for cancer drug development and improving treatment effectiveness.
Area of Science:
- Bioinformatics
- Systems Biology
- Genomics
Background:
- Chemotherapy resistance significantly hinders cancer treatment efficacy.
- Mechanisms underlying chemotherapy resistance remain largely undefined.
- Identifying chemoresistance-associated pathways and genes is crucial for therapeutic advancement.
Purpose of the Study:
- To elucidate chemoresistance-associated pathways using integrated biological networks.
- To identify signature genes critical for chemotherapy resistance.
- To uncover potential therapeutic targets for overcoming drug resistance.
Main Methods:
- Constructed an integrated biological network from public metabolic interaction databases.
- Applied the k-shortest path algorithm to identify chemoresistance-related pathways.
- Scored pathways using differential gene expression data from microarray analysis of ovarian and lung cancers.
- Utilized the Reactome database to assess gene significance based on topological features.
Main Results:
- Discovered novel pathways specifically associated with chemoresistance.
- Confirmed consistency with known chemotherapy resistance mechanisms.
- Demonstrated that integrating pathway structure with gene expression reveals distinct modes of gene action in chemoresistance.
- Identified signature genes involved in drug resistance and potential key targets for cancer therapy.
Conclusions:
- The study successfully identified potential therapeutic targets for chemoresistance.
- Highlighted the interconnected nature of chemoresistance mechanisms.
- Provided insights into the biological actions of drug resistance and generated new hypotheses for drug development.
More Related Videos
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
09:19Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:56Treatment Resistant Cancers
01:19Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...